Surgery does not affect the number of circulating tumour cells in the bone marrow of patients with breast carcinoma
β Scribed by N. J. Aherne; K. C. Redmond; J. H. Wang; E. T. Condon; J. Kelly; D. Richardson; H. P. Redmond
- Publisher
- Springer-Verlag
- Year
- 2002
- Tongue
- English
- Weight
- 397 KB
- Volume
- 171
- Category
- Article
- ISSN
- 1863-4362
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Using cytokeratin (ck) as a histogenetic marker of epithelial tumor cells in the bone marrow of patients with primary breast carcinoma, a subgroup of patients with decreased survival can be identified. this study was designed to evaluate the frequency and prognostic relevance of such
## Abstract Detection of disseminated tumor cells (DTCs) in bone marrow is an independent prognostic factor in primary breast cancer. Here, we conducted a proofβofβprinciple study to evaluate whether this tumor cell spread occurs already in patients with ductal carcinoma in situ (DCIS). After preop